While it was quiet trading in Australia last week because of a major thoroughbred carnival they hold annually down under, there's a lot about to happen in most sectors as their eyes return to the bourse away from the bookmakers. We suggest you look closely at the following:
Heathlinx (ASX: Code: HTX) An emerging Australian biotech in the popular diagnostic sphere. Seems to be following the "same path" as (Dendreon Nasdaq: DNDN) and (Prima BioMed ASX Code: PRR) including the New York financing.
William Bailey Wall Street Finance
HTX Price at posting:
11.5¢ Sentiment: Buy Disclosure: Held
